Iprindole and Imipramine in Non-Psychotic Depressed Out-Patients

Authors:
  • KRKarl Rickels
    Karl Rickels
  • HCHack R. Chung
    Hack R. Chung
  • ICIrma Csanalosi
    Irma Csanalosi
  • LSLester Sablosky
    Lester Sablosky
  • JSJoseph H. Simon
    Joseph H. Simon

Abstract
In an earlier study this research group reported iprindole, a relatively new tricyclic derivative, to be an effective drug for use in depressed neurotic out-patients (ii). We found it to produce significantly greater improvement than placebo on a variety of outcome measures. Good response to iprindole as compared to placebo has also been reported by Hicks (5) and Daneman (3). Sterlin et al., comparing iprindole with amitriptyline in a relatively small patient sample, reported that iprindole, while faster acting, produced less overall improvement (15); differences in improvement did not, however, reach statistical significance.

This publication has 8 references indexed in Scilit: